Skip to main content

Table 2 Demographics and clinical differences between Intravesical BCG related granulomatous and non-granulomatous disease

From: Emerging concepts and spectrum of renal injury following Intravesical BCG for non-muscle invasive bladder cancer

 

No. Granuloma (n = 8)

Granuloma (n = 7)

p =

Gender n = (M, F)

8, 0

5, 2

NA

Age (Years)

72 (58–76)

70 (67–73)

0.48

No. of Instillations

9.5 (8.25–11.5)

13.5 (8–18)

0.40

BCG Strains

Pas, Tice, Conn

Pas, Onc Tice, Conn

 

Peak creatinine (mg/dL)

4.6 (1.9–6.4)

3 (1.7–3.8)

0.28

Required HD (n=)

3

0

 

Death (n = 3)

 17 -day

1

  

 32-day

1

  

 1-year

1

  

Recovery (n = 15)

  

 Partial/None

6

2

 Complete

2

5